S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
S&P 500   3,321.75 (+0.03%)
DOW   29,186.27 (-0.03%)
QQQ   223.87 (+0.26%)
AAPL   317.70 (+0.36%)
FB   221.32 (-0.05%)
MSFT   165.70 (-0.48%)
GOOGL   1,484.17 (+0.13%)
AMZN   1,887.46 (-0.24%)
CGC   24.12 (-0.12%)
NVDA   250.05 (+0.85%)
BABA   222.37 (+0.05%)
MU   59.17 (+0.34%)
GE   11.37 (-2.49%)
TSLA   569.56 (+4.09%)
AMD   51.43 (+0.74%)
T   39.04 (+1.35%)
ACB   2.04 (+1.49%)
F   9.16 (-0.54%)
NFLX   326.00 (-3.58%)
PRI   126.65 (+0.19%)
BAC   34.36 (+0.29%)
DIS   144.01 (+0.31%)
GILD   63.43 (+1.28%)
Log in

Hancock Jaffe Laboratories SEC Filings & 10K Form (NASDAQ:HJLI)

$0.58
-0.01 (-1.69 %)
(As of 01/22/2020 04:00 PM ET)
Today's Range
$0.53
Now: $0.58
$0.59
50-Day Range
$0.38
MA: $0.51
$0.72
52-Week Range
$0.38
Now: $0.58
$3.45
Volume42,561 shs
Average Volume121,405 shs
Market Capitalization$10.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22

SEC Filings

Hancock Jaffe Laboratories (NASDAQ:HJLI) SEC Filings

DateFilerForm TypeView
12/11/2019
3:30 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:05 PM
Hancock Jaffe Laboratories (Issuer)
Shrivastava Sanjay (Reporting)
Form 4/A
10/31/2019
4:16 PM
Hancock Jaffe Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2019
4:00 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2019
3:30 PM
Gray Robert (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2019
5:47 PM
Gray Robert (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2019
3:30 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
4:23 PM
Hancock Jaffe Laboratories (Subject)
Zhivilo Yury (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2019
4:15 PM
Hancock Jaffe Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
4:10 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
4:44 PM
Glickman Marc H. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/26/2019
3:15 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2019
4:25 PM
Hancock Jaffe Laboratories (Filer)
Form 424B4
06/11/2019
11:15 PM
Hancock Jaffe Laboratories (Filer)
Form EFFECT
06/07/2019
4:29 PM
Hancock Jaffe Laboratories (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/07/2019
7:45 AM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2019
4:30 PM
Biodyne Holding, S.A. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
7:30 AM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
4:29 PM
Hancock Jaffe Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
4:01 PM
Hancock Jaffe Laboratories (Filer)
Form 424B3
05/06/2019
11:15 PM
Hancock Jaffe Laboratories (Filer)
Form EFFECT
05/03/2019
4:13 PM
Hancock Jaffe Laboratories (Filer)
Form D/A
04/30/2019
7:56 PM
Hancock Jaffe Laboratories (Filer)
Form POS AM
04/30/2019
7:35 AM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
11:15 PM
Hancock Jaffe Laboratories (Filer)
Form EFFECT
04/17/2019
5:47 PM
BERMAN ROBERT ANDREW (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4/A
04/16/2019
3:11 PM
Hancock Jaffe Laboratories (Filer)
Form D
Notice of Exempt Offering of Securities 
03/29/2019
11:46 AM
Hancock Jaffe Laboratories (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/14/2019
5:52 PM
BERMAN ROBERT ANDREW (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
8:00 AM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2018
5:11 AM
ACT Capital Management, LLLP (Filed by)
Hancock Jaffe Laboratories (Subject)
Form SC 13G/A
12/21/2018
2:56 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2018
4:05 PM
Duhay Francis (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
4:00 PM
Duhay Francis (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/29/2018
4:31 PM
Hancock Jaffe Laboratories (Issuer)
Robins Marcus W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
4:31 PM
Hancock Jaffe Laboratories (Issuer)
Shrivastava Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
4:31 PM
Broennimann Benedict (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
4:28 PM
Hancock Jaffe Laboratories (Filer)
Form DEF 14A
11/07/2018
3:29 PM
Hancock Jaffe Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/12/2018
1:24 PM
Hancock Jaffe Laboratories (Issuer)
Robins Marcus W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/12/2018
10:57 AM
Hancock Jaffe Laboratories (Issuer)
Shrivastava Sanjay (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2018
12:27 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2018
2:25 PM
BERMAN ROBERT ANDREW (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
7:40 AM
Cantor Steven A. (Reporting)
Hancock Jaffe Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/10/2018
6:41 PM
Cantor Steven A. (Filed by)
Hancock Jaffe Laboratories (Subject)
Form SC 13G
08/10/2018
3:38 PM
Hancock Jaffe Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2018
4:26 PM
Hancock Jaffe Laboratories (Issuer)
Rankin Robert A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/20/2018
4:13 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
11:15 PM
Hancock Jaffe Laboratories (Filer)
Form EFFECT
06/15/2018
11:31 AM
ACT Capital Management, LLLP (Filed by)
Hancock Jaffe Laboratories (Subject)
Form SC 13G
06/14/2018
3:41 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
1:31 PM
Hancock Jaffe Laboratories (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/12/2018
1:15 PM
Hancock Jaffe Laboratories (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2018
4:20 PM
Hancock Jaffe Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
4:09 PM
Hancock Jaffe Laboratories (Filer)
Form 424B4
06/01/2018
4:06 PM
Hancock Jaffe Laboratories (Filer)
Form 424B4
05/31/2018
8:22 AM
Hancock Jaffe Laboratories (Filer)
Form S-1MEF
05/30/2018
11:15 PM
Hancock Jaffe Laboratories (Filer)
Form EFFECT
05/30/2018
8:59 PM
Hancock Jaffe Laboratories (Issuer)
Montoya Susan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:59 PM
BERMAN ROBERT ANDREW (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:59 PM
Glickman Marc H. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Hancock Jaffe Laboratories (Issuer)
Zhivilo Yury (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Browston Trading Ltd (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
GIRGENTI STEVEN (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Broennimann Benedict (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Doyle Robert W. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Biodyne Holding, S.A. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Anderson Robert A. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:58 PM
Cantor Steven A. (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
8:57 PM
ABBOTT WILLIAM R (Reporting)
Hancock Jaffe Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/30/2018
2:35 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
05/25/2018
1:17 PM
Hancock Jaffe Laboratories (Filer)
Form 8-A12B/A
05/22/2018
3:32 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
05/14/2018
4:21 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
04/24/2018
2:27 PM
Hancock Jaffe Laboratories (Subject)
Form FWP
04/13/2018
8:07 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
03/09/2018
8:42 PM
Hancock Jaffe Laboratories (Subject)
Form FWP
03/01/2018
7:54 PM
Hancock Jaffe Laboratories (Subject)
Form FWP
01/26/2018
4:31 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
12/14/2017
1:24 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
12/12/2017
4:25 PM
Hancock Jaffe Laboratories (Filer)
Form 8-A12B
12/05/2017
2:02 PM
Hancock Jaffe Laboratories (Subject)
Form FWP
12/05/2017
2:00 PM
Hancock Jaffe Laboratories (Filer)
Form S-1/A
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel